BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9025901)

  • 1. Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts.
    Welsh GI; Patel JC; Proud CG
    Anal Biochem; 1997 Jan; 244(1):16-21. PubMed ID: 9025901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts.
    Ryves WJ; Fryer L; Dale T; Harwood AJ
    Anal Biochem; 1998 Nov; 264(1):124-7. PubMed ID: 9784196
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of glucose and the hexosamine biosynthesis pathway on glycogen synthase kinase-3 and other protein kinases that regulate glycogen synthase activity.
    Singh LP; Crook ED
    J Investig Med; 2000 Jul; 48(4):251-8. PubMed ID: 10916283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3.
    Wang QM; Roach PJ; Fiol CJ
    Anal Biochem; 1994 Aug; 220(2):397-402. PubMed ID: 7978284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glycogen synthase kinase-3 by insulin in cultured human skeletal muscle myoblasts.
    Borthwick AC; Wells AM; Rochford JJ; Hurel SJ; Turnbull DM; Yeaman SJ
    Biochem Biophys Res Commun; 1995 May; 210(3):738-45. PubMed ID: 7763247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear glycogen and glycogen synthase kinase 3.
    Ragano-Caracciolo M; Berlin WK; Miller MW; Hanover JA
    Biochem Biophys Res Commun; 1998 Aug; 249(2):422-7. PubMed ID: 9712712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes.
    González-Yanes C; Sánchez-Margalet V
    Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.
    Liu Z; Wu Y; Nicklas EW; Jahn LA; Price WJ; Barrett EJ
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E523-8. PubMed ID: 14656717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3.
    Plotkin B; Kaidanovich O; Talior I; Eldar-Finkelman H
    J Pharmacol Exp Ther; 2003 Jun; 305(3):974-80. PubMed ID: 12626660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
    Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
    Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of cellular activity and protein level of protein kinase FA/GSK-3 alpha correlates with human thyroid tumor cell dedifferentiation.
    Lee TT; Ho YS; Yu JS; Yang SD
    J Cell Biochem; 1995 Aug; 58(4):474-80. PubMed ID: 7593269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
    Sharfi H; Eldar-Finkelman H
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of GSK-3 by affinity chromatography on immobilized axin.
    Primot A; Baratte B; Gompel M; Borgne A; Liabeuf S; Romette JL; Jho EH; Costantini F; Meijer L
    Protein Expr Purif; 2000 Dec; 20(3):394-404. PubMed ID: 11087679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter.
    Lau KF; Miller CC; Anderton BH; Shaw PC
    Genomics; 1999 Sep; 60(2):121-8. PubMed ID: 10486203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin.
    Welsh GI; Miller CM; Loughlin AJ; Price NT; Proud CG
    FEBS Lett; 1998 Jan; 421(2):125-30. PubMed ID: 9468292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle.
    Jefferson LS; Fabian JR; Kimball SR
    Int J Biochem Cell Biol; 1999 Jan; 31(1):191-200. PubMed ID: 10216953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge.
    Bullock BP; Habener JF
    Biochemistry; 1998 Mar; 37(11):3795-809. PubMed ID: 9521699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view.
    Tilleman K; Stevens I; Spittaels K; Haute CV; Clerens S; Van Den Bergh G; Geerts H; Van Leuven F; Vandesande F; Moens L
    Proteomics; 2002 Jan; 2(1):94-104. PubMed ID: 11788996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T; Vidal-Puig A
    Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.